A substantial advancement in diabetes care is emerging with the introduction of tirzepatide at a dosage of 45mg. This updated offering builds upon the existing success of tirzepatide, a dual GIP and GLP-1 agonist, and https://barbarapzsh259390.wikisona.com/user